Back to results
US 2022/0331418 A1Published application
Methods and Compositions for Activation of Innate Immune Responses Through RIG-I Like Receptor Signaling
AssigneeUniversity of Washington through its Center for Commercialization
InventorsMichael J. Gale, JR., Gretja Schnell, Yueh-Ming Loo
Life of this patent
Estimating the term…
Abstract
Compositions and methods are provided that enable activation of innate immune responses through RIG-I like receptor signaling. The compositions and methods incorporate synthetic nucleic acid pathogen associated molecular patterns (PAMPs) that comprise elements initially characterized in, and derived from, the hepatitis C virus genome.
Claims18
A pharmaceutical composition, wherein the pharmaceutical composition comprises:
- an isolated nucleic acid molecule comprising sequence of SEQ ID NO:
- 1;
- and
- a carrier.
1 more element
Dependencies are inferred from the claim text.